Alterola Biotech, Inc. — Operating Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/11f37369-37c7-4b52-afb3-50693526b2f9/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-2.1M | 2023-04-01 – 2024-03-31 | evidence 0001663577-24-000211 |
| FY 2022 | $-2.0M | 2022-04-01 – 2023-03-31 | evidence 0001663577-24-000211 |
| FY 2021 | $-6.5M | 2021-04-01 – 2022-03-31 | evidence 0001663577-22-000372 |
| FY 2020 | $-309.5k | 2020-04-01 – 2021-03-31 | evidence 0001663577-22-000372 |
| FY 2019 | $-258.5k | 2018-10-01 – 2019-09-30 | evidence 0001663577-21-000147 |
| FY 2018 | $-122.6k | 2017-10-01 – 2018-09-30 | evidence 0001663577-20-000468 |
| FY 2017 | $-49.1k | 2016-10-01 – 2017-09-30 | evidence 0001663577-18-000560 |
| FY 2016 | $-14.7k | 2015-10-01 – 2016-09-30 | evidence 0001663577-18-000400 |
| FY 2015 | $-20.4k | 2014-10-01 – 2015-09-30 | evidence 0001662252-15-000008 |
| FY 2014 | $-40.9k | 2013-10-01 – 2014-09-30 | evidence 0001255294-15-000022 |
| FY 2013 | $-437.7k | 2008-07-21 – 2014-03-31 | evidence 0001255294-14-000459 |
| FY 2012 | $-359.2k | 2008-07-21 – 2013-03-31 | evidence 0001255294-14-000191 |
| FY 2011 | $-355.5k | 2008-07-21 – 2012-03-31 | evidence 0001255294-14-000148 |
| FY 2010 | $-126.8k | 2009-10-01 – 2010-09-30 | evidence 0001255294-14-000122 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).